Cardiac MRI for Detecting Early Cardiac Toxicity after Proton Therapy for Hodgkin Lymphoma

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Consolidative proton therapy after chemotherapy for patients with Hodgkin lymphoma

Background We investigated early outcomes for patients receiving chemotherapy followed by consolidative proton therapy (PT) for the treatment of Hodgkin lymphoma (HL). Patients and methods From June 2008 through August 2015, 138 patients with HL enrolled on either IRB-approved outcomes tracking protocols or registry studies received consolidative PT. Patients were excluded due to relapsed or ...

متن کامل

Late Cardiac Effects of Therapy for Hodgkin Lymphoma

Hodgkin lymphoma (HL) is a leading cause of cancer among adolescents, and is often cured with chemotherapy alone or in combination with radiation therapy. Awareness of potential adverse cardiovascular sequelae due to therapy is crucial. Radiation-induced heart disease can affect cardiovascular structures in the radiation field, and risks of cardiovascular damage can be further increased due to ...

متن کامل

Cardiac MRI for the assessment of early chemotherapeutic cardiac injury and toxicity

Background Chemotherapeutically induced myocardial injury continues to pose a major problem. The exact mechanism of drug-related cardiomyopathy (DRC) is still poorly understood. An early diagnosis of cardiotoxicity and the ability to predict patients at risk are important for preventing chronic heart failure. The guidelines for noninvasive cardiac imaging to screen for DRC show limitations in e...

متن کامل

iev (ifosfamide, epirubicin, vp16) regimen as salvage therapy for early relapsed/refractory non-hodgkin/hodgkin lymphoma

introduction: management of early relapsed or refractory lymphoma [hodgkin & non- hodgkin lymphoma (hl & nhl)] is a matter of problem, especially when hematopietic stem cell support is not available. the aim of this study was to evaluate effectiveness of iev regimen ( ifosfamide, epirubicin, vp16), in lymphoma patients who are not candidate for stem cell transplantation. because the majority of...

متن کامل

Late radiation toxicity in Hodgkin lymphoma patients: proton therapy's potential

In 2010, all young patients treated for intrathoracic Hodgkin lymphoma (HL) at one of 10 radiotherapy centers in the province of Quebec received 3D conformal photon therapy. These patients may now be at risk for late effects of their treatment, notably secondary malignancies and cardiac toxicity. We hypothesized that more complex radiotherapy, including intensity-modulated proton therapy (IMPT)...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: International Journal of Particle Therapy

سال: 2019

ISSN: 2331-5180

DOI: 10.14338/ijpt-19-00052.1